Media formats available:
Recommended
- SGLT2 inhibition in CKD: Discussing the key questions and evidenceOutcomes of SGLT2i in Diabetic Kidney Disease: Is it all diabetes?
Rajiv Agarwal, MD
- SGLT2 inhibition in CKD: Discussing the key questions and evidenceThe clinical landscape of managing patients with CKD: Where are we now and what can we expect?
Will Herrington, MD